Breaking News Instant updates and real-time market news.

KNSA

Kiniksa

$12.93 /

+1.49 (+13.02%)

, GILD

Gilead

$67.07 /

+0.13 (+0.19%)

08:33
12/11/19
12/11
08:33
12/11/19
08:33

Kiniksa, Kite announce collaboration for study of mavrilimumab w/ Yescarta

Kite, a Gilead Company (GILD), and Kiniksa Pharmaceuticals, Ltd. (KNSA) announced that the companies have entered into a clinical collaboration to conduct a Phase 2, multicenter study of mavrilimumab, an investigational fully human monoclonal antibody that targets granulocyte macrophage colony stimulating factor receptor alpha, in combination with Yescarta in patients with relapsed or refractory large B-cell lymphoma. The objective of the study is to determine the effect of mavrilimumab on the safety of Yescarta. Kite will be the sponsor of this study and will be responsible for its conduct. Treatment related induction of GM-CSF has been identified through clinical, translational and preclinical studies as a potential key signal associated with side effects of chimeric antigen receptor T cell therapy. Preclinical evidence shows the potential for interruption of GM-CSF signaling to disrupt CAR T cell mediated inflammation without disrupting anti-tumor efficacy. Yescarta was the first CAR T cell therapy to be approved by the U.S. Food and Drug Administration for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma not otherwise specified, primary mediastinal large B-cell lymphoma, and high grade B-cell lymphoma and DLBCL arising from follicular lymphoma. Yescarta is not indicated for the treatment of patients with primary central nervous system lymphoma. Mavrilimumab, alone or in combination with other therapies such as Yescarta, is investigational and has not been approved by the FDA or any regulatory authority for any uses. Efficacy and safety have not been established.

KNSA

Kiniksa

$12.93 /

+1.49 (+13.02%)

GILD

Gilead

$67.07 /

+0.13 (+0.19%)

KNSA Kiniksa
$12.93 /

+1.49 (+13.02%)

12/06/19 Goldman Sachs
Kiniksa assumed to Buy from Neutral at Goldman Sachs
08/14/19 JMP Securities
Kiniksa price target lowered to $35 from $44 at JMP Securities
03/11/19 Barclays
Kiniksa initiated with an Overweight at Barclays
GILD Gilead
$67.07 /

+0.13 (+0.19%)

11/15/19 RBC Capital
Galapagos price target raised to $158 from $152 at RBC Capital
11/12/19 Truist
Gilead initiated with a Hold at SunTrust
10/29/19 RBC Capital
Gilead design of Phase 2 study of GS-6207 'intriguing,' says RBC Capital
10/25/19 Oppenheimer
Gilead price target lowered to $80 from $85 at Oppenheimer

TODAY'S FREE FLY STORIES

Hot Stocks
WaterMill announces Glass Lewis endorsement for change to Ziopharm board » 05:45
12/03/20
12/03
05:45
12/03/20
05:45
ZIOP

Ziopharm

$2.78 /

-0.075 (-2.63%)

WaterMill Asset…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZIOP Ziopharm
$2.78 /

-0.075 (-2.63%)

ZIOP Ziopharm
$2.78 /

-0.075 (-2.63%)

07/10/20 Lake Street
Ziopharm took 'important step' with start of CAR-T study, says Lake Street
06/19/20 Jefferies
Ziopharm initiated with a Buy at Jefferies
05/11/20 H.C. Wainwright
Ziopharm price target lowered to $5.50 from $6.50 at H.C. Wainwright
03/04/20
Fly Intel: Top five analyst initiations
ZIOP Ziopharm
$2.78 /

-0.075 (-2.63%)

  • 05
    Feb
ZIOP Ziopharm
$2.78 /

-0.075 (-2.63%)

ZIOP Ziopharm
$2.78 /

-0.075 (-2.63%)

Upgrade
Wartsila upgraded to Hold on energy storage potential at HSBC » 05:45
12/03/20
12/03
05:45
12/03/20
05:45
WRTBY

Wartsila

$0.00 /

+ (+0.00%)

HSBC analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WRTBY Wartsila
$0.00 /

+ (+0.00%)

05:16 Today HSBC
Wartsila upgraded to Hold from Reduce at HSBC
10/26/20 Morgan Stanley
Wartsila price target lowered to EUR 7.60 from EUR 8.10 at Morgan Stanley
10/26/20 JPMorgan
Wartsila downgraded to Underweight from Neutral at JPMorgan
10/13/20 Goldman Sachs
Wartsila downgraded to Neutral from Buy at Goldman Sachs
Hot Stocks
Microsoft acquires eports platform company Smash.gg; terms not disclosed » 05:45
12/03/20
12/03
05:45
12/03/20
05:45
MSFT

Microsoft

$215.40 /

-0.67 (-0.31%)

Microsoft has acquired…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$215.40 /

-0.67 (-0.31%)

MSFT Microsoft
$215.40 /

-0.67 (-0.31%)

12/02/20 Stephens
Stephens upgrades ACI Worldwide to Overweight after Starboard urges sale
12/02/20 Stephens
Slack Technologies downgraded to Equal Weight from Overweight at Stephens
11/30/20 Northland
Plantronics price target raised to $40 from $30 at Northland
11/27/20 MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
MSFT Microsoft
$215.40 /

-0.67 (-0.31%)

MSFT Microsoft
$215.40 /

-0.67 (-0.31%)

MSFT Microsoft
$215.40 /

-0.67 (-0.31%)

MSFT Microsoft
$215.40 /

-0.67 (-0.31%)

Hot Stocks
Flowers Foods recalls bread, everything bagels due to potential gluten presence » 05:41
12/03/20
12/03
05:41
12/03/20
05:41
FLO

Flowers Foods

$22.12 /

-0.38 (-1.69%)

Flowers Foods is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLO Flowers Foods
$22.12 /

-0.38 (-1.69%)

FLO Flowers Foods
$22.12 /

-0.38 (-1.69%)

05/15/20 SunTrust
Flowers Foods price target raised to $25 from $20 at SunTrust
01/22/20 Jefferies
Flowers Foods initiated with a Hold at Jefferies
01/22/20 Jefferies
Flowers Foods initiated with a Hold at Jefferies
12/11/19 Deutsche Bank
Flowers Foods resumed with a Hold at Deutsche Bank
FLO Flowers Foods
$22.12 /

-0.38 (-1.69%)

Downgrade
Splunk downgraded to Neutral from Overweight at JPMorgan » 05:40
12/03/20
12/03
05:40
12/03/20
05:40
SPLK

Splunk

$205.91 /

-0.48 (-0.23%)

JPMorgan analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

05:16 Today Stifel
Splunk downgraded to Hold from Buy at Stifel
05:15 Today Summit Insights
Splunk downgraded to Hold from Buy at Summit Insights
11/25/20 Cowen
Cowen sees 'a lot of moving parts' into Splunk's Q3 results
11/23/20 KeyBanc
Splunk initiated with an Overweight at KeyBanc
SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

Upgrade
Empire State Realty upgraded to Outperform from Market Perform at BMO Capital » 05:39
12/03/20
12/03
05:39
12/03/20
05:39
ESRT

Empire State Realty

$9.45 /

+0.17 (+1.83%)

BMO Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESRT Empire State Realty
$9.45 /

+0.17 (+1.83%)

ESRT Empire State Realty
$9.45 /

+0.17 (+1.83%)

09/03/20 Citi
Empire State Realty upgraded to Neutral from Sell at Citi
08/28/20 BMO Capital
Empire State Realty upgraded to Market Perform from Underperform at BMO Capital
04/07/20 Citi
Empire State Realty downgraded to Sell from Neutral at Citi
03/12/20 BMO Capital
Empire State Realty cut to Underperform from Market Perform at BMO Capital
ESRT Empire State Realty
$9.45 /

+0.17 (+1.83%)

ESRT Empire State Realty
$9.45 /

+0.17 (+1.83%)

Hot Stocks
Yamana Gold provides update on generative exploration program activities » 05:38
12/03/20
12/03
05:38
12/03/20
05:38
AUY

Yamana Gold

$5.52 /

+0.025 (+0.46%)

Yamana Gold provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUY Yamana Gold
$5.52 /

+0.025 (+0.46%)

AUY Yamana Gold
$5.52 /

+0.025 (+0.46%)

11/16/20 BMO Capital
Yamana Gold upgraded to Outperform from Market Perform at BMO Capital
11/04/20 Berenberg
Yamana Gold price target raised to 610 GBp from 590 GBp at Berenberg
10/22/20 National Bank
Yamana Gold price target lowered to C$9 from C$9.50 at National Bank
10/14/20 Berenberg
Yamana Gold initiated with a Buy at Berenberg
AUY Yamana Gold
$5.52 /

+0.025 (+0.46%)

AUY Yamana Gold
$5.52 /

+0.025 (+0.46%)

AUY Yamana Gold
$5.52 /

+0.025 (+0.46%)

Upgrade
Essex Property upgraded to Market Perform from Underperform at BMO Capital » 05:37
12/03/20
12/03
05:37
12/03/20
05:37
ESS

Essex Property Trust

$248.77 /

+2 (+0.81%)

BMO Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESS Essex Property Trust
$248.77 /

+2 (+0.81%)

11/20/20 Morgan Stanley
Essex Property Trust price target raised to $279 from $215 at Morgan Stanley
11/12/20 BTIG
Essex Property Trust upgraded to Buy from Neutral at BTIG
11/12/20 BTIG
Essex Property Trust upgraded to Buy from Neutral at BTIG
11/10/20 Mizuho
Essex Property Trust upgraded to Buy from Neutral at Mizuho
ESS Essex Property Trust
$248.77 /

+2 (+0.81%)

Recommendations
Piper boosts ShockWave Medical target to $96, likes setup into 2021 » 05:35
12/03/20
12/03
05:35
12/03/20
05:35
SWAV

ShockWave Medical

$86.27 /

-7.03 (-7.53%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$86.27 /

-7.03 (-7.53%)

SWAV ShockWave Medical
$86.27 /

-7.03 (-7.53%)

12/02/20 Oppenheimer
Oppenheimer stays at Perform on ShockWave, highlights paper on IVL-induced VFib
12/01/20 BofA
ShockWave Medical downgraded to Neutral from Buy at BofA
11/10/20 Wells Fargo
ShockWave Medical price target raised to $95 from $90 at Wells Fargo
11/10/20 Piper Sandler
ShockWave Medical price target raised to $93 from $86 at Piper Sandler
SWAV ShockWave Medical
$86.27 /

-7.03 (-7.53%)

  • 17
    Jun
Hot Stocks
Jazz Pharmaceuticals announces ATLANTIS study did not meet primary endpoint » 05:30
12/03/20
12/03
05:30
12/03/20
05:30
JAZZ

Jazz Pharmaceuticals

$144.49 /

+1.23 (+0.86%)

Jazz Pharmaceuticals,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$144.49 /

+1.23 (+0.86%)

JAZZ Jazz Pharmaceuticals
$144.49 /

+1.23 (+0.86%)

11/03/20 SVB Leerink
Jazz Pharmaceuticals price target raised to $202 from $194 at SVB Leerink
11/03/20 Wells Fargo
Jazz Pharmaceuticals price target raised to $184 from $171 at Wells Fargo
11/03/20 RBC Capital
Jazz Pharmaceuticals price target raised to $180 from $170 at RBC Capital
11/03/20 Barclays
Jazz Pharmaceuticals price target raised to $233 from $225 at Barclays
JAZZ Jazz Pharmaceuticals
$144.49 /

+1.23 (+0.86%)

JAZZ Jazz Pharmaceuticals
$144.49 /

+1.23 (+0.86%)

Hot Stocks
IBM selected by Piaggio to transition management applications to SAP S/4HANA » 05:26
12/03/20
12/03
05:26
12/03/20
05:26
IBM

IBM

$124.58 /

+1.42 (+1.15%)

, PIAGF

Piaggio

$0.00 /

+ (+0.00%)

IBM (IBM) and Piaggio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBM IBM
$124.58 /

+1.42 (+1.15%)

IBM IBM
$124.58 /

+1.42 (+1.15%)

10/20/20 Morgan Stanley
Morgan Stanley continues to view IBM as 'a 2022 stock'
10/20/20 Citi
IBM is 'getting even more complex,' says Citi
10/20/20 BMO Capital
IBM price target lowered to $138 from $140 at BMO Capital
10/09/20 Morgan Stanley
IBM price target raised to $140 from $128 at Morgan Stanley
PIAGF Piaggio
$0.00 /

+ (+0.00%)

11/02/20 Kepler Cheuvreux
Piaggio upgraded to Hold from Reduce at Kepler Cheuvreux
05/11/20 Kepler Cheuvreux
Piaggio downgraded to Reduce from Hold at Kepler Cheuvreux
IBM IBM
$124.58 /

+1.42 (+1.15%)

IBM IBM
$124.58 /

+1.42 (+1.15%)

IBM IBM
$124.58 /

+1.42 (+1.15%)

IBM IBM
$124.58 /

+1.42 (+1.15%)

Recommendations
Inspire Medical price target raised to $210 from $147 at Piper Sandler » 05:24
12/03/20
12/03
05:24
12/03/20
05:24
INSP

Inspire Medical

$191.38 /

+1.38 (+0.73%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INSP Inspire Medical
$191.38 /

+1.38 (+0.73%)

INSP Inspire Medical
$191.38 /

+1.38 (+0.73%)

11/03/20
Fly Intel: Top five analyst upgrades
11/03/20 SVB Leerink
Inspire Medical price target raised to $170 from $150 at SVB Leerink
11/03/20 Wells Fargo
Inspire Medical price target raised to $140 from $135 at Wells Fargo
11/03/20 Baird
Inspire Medical price target raised to $160 from $130 at Baird
INSP Inspire Medical
$191.38 /

+1.38 (+0.73%)

  • 14
    Apr
INSP Inspire Medical
$191.38 /

+1.38 (+0.73%)

Hot Stocks
IBM contracted by ABB to support procurement digitization with SmartBuy launch » 05:23
12/03/20
12/03
05:23
12/03/20
05:23
IBM

IBM

$124.58 /

+1.42 (+1.15%)

, ABB

ABB

$26.55 /

-0.12 (-0.45%)

IBM (IBM) announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBM IBM
$124.58 /

+1.42 (+1.15%)

ABB ABB
$26.55 /

-0.12 (-0.45%)

IBM IBM
$124.58 /

+1.42 (+1.15%)

10/20/20 Morgan Stanley
Morgan Stanley continues to view IBM as 'a 2022 stock'
10/20/20 Citi
IBM is 'getting even more complex,' says Citi
10/20/20 BMO Capital
IBM price target lowered to $138 from $140 at BMO Capital
10/09/20 Morgan Stanley
IBM price target raised to $140 from $128 at Morgan Stanley
ABB ABB
$26.55 /

-0.12 (-0.45%)

11/20/20 UBS
ABB price target raised to CHF 28 from CHF 27 at UBS
11/20/20 JPMorgan
ABB price target raised to CHF 22 from CHF 21.50 at JPMorgan
11/20/20 Deutsche Bank
ABB downgraded to Sell from Hold at Deutsche Bank
10/26/20 JPMorgan
ABB price target raised to CHF 21.50 from CHF 20 at JPMorgan
IBM IBM
$124.58 /

+1.42 (+1.15%)

ABB ABB
$26.55 /

-0.12 (-0.45%)

IBM IBM
$124.58 /

+1.42 (+1.15%)

ABB ABB
$26.55 /

-0.12 (-0.45%)

IBM IBM
$124.58 /

+1.42 (+1.15%)

IBM IBM
$124.58 /

+1.42 (+1.15%)

ABB ABB
$26.55 /

-0.12 (-0.45%)

Downgrade
Omnicell downgraded to Neutral from Overweight at Cantor Fitzgerald » 05:21
12/03/20
12/03
05:21
12/03/20
05:21
OMCL

Omnicell

$108.25 /

+1.26 (+1.18%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMCL Omnicell
$108.25 /

+1.26 (+1.18%)

OMCL Omnicell
$108.25 /

+1.26 (+1.18%)

10/28/20 Craig-Hallum
Omnicell price target raised to $100 from $85 at Craig-Hallum
10/28/20 Wells Fargo
Omnicell price target raised to $84 from $74 at Wells Fargo
10/28/20 Cantor Fitzgerald
Omnicell price target raised to $95 from $90 at Cantor Fitzgerald
10/28/20 Piper Sandler
Omnicell price target raised to $86 from $70 at Piper Sandler
OMCL Omnicell
$108.25 /

+1.26 (+1.18%)

Downgrade
Ambev downgraded to Underweight from Equal Weight at Morgan Stanley » 05:20
12/03/20
12/03
05:20
12/03/20
05:20
ABEV

Ambev

$2.88 /

+0.025 (+0.88%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABEV Ambev
$2.88 /

+0.025 (+0.88%)

11/02/20 Citi
Ambev upgraded to Buy on 'impressive' execution at Citi
11/02/20 Citi
Ambev upgraded to Buy from Neutral at Citi
09/14/20 HSBC
Ambev upgraded to Hold from Reduce at HSBC
07/31/20 JPMorgan
Ambev upgraded to Neutral from Underweight at JPMorgan
ABEV Ambev
$2.88 /

+0.025 (+0.88%)

ABEV Ambev
$2.88 /

+0.025 (+0.88%)

Upgrade
Grupo Lala upgraded to Overweight from Underweight at Morgan Stanley » 05:20
12/03/20
12/03
05:20
12/03/20
05:20
GRPBF

Grupo Lala

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRPBF Grupo Lala
$0.00 /

+ (+0.00%)

10/22/20 Barclays
Grupo Lala upgraded to Equal Weight from Underweight at Barclays
10/15/20 Scotiabank
Grupo Lala upgraded to Sector Perform from Underperform at Scotiabank
01/21/20 Goldman Sachs
Grupo Lala downgraded to Sell from Neutral at Goldman Sachs
01/21/20 Goldman Sachs
Grupo Lala upgraded to Buy from Neutral at Goldman Sachs
Downgrade
Femsa downgraded to Equal Weight from Overweight at Morgan Stanley » 05:19
12/03/20
12/03
05:19
12/03/20
05:19
FMX

Femsa

$77.60 /

+1.475 (+1.94%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMX Femsa
$77.60 /

+1.475 (+1.94%)

FMX Femsa
$77.60 /

+1.475 (+1.94%)

11/30/20 Itau BBA
Femsa downgraded to Market Perform from Outperform at Itau BBA
05/04/20 BofA
Femsa downgraded to Underperform from Neutral at BofA
01/07/20 Citi
Femsa upgraded to Buy from Neutral at Citi
FMX Femsa
$77.60 /

+1.475 (+1.94%)

Downgrade
Trip.com Group downgraded to Neutral from Buy at New Street » 05:18
12/03/20
12/03
05:18
12/03/20
05:18
TCOM

Trip.com Group

$33.18 /

-1.23 (-3.57%)

New Street analyst Jin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCOM Trip.com Group
$33.18 /

-1.23 (-3.57%)

12/02/20 New Street
Trip.com Group downgraded to Neutral from Buy at New Street
12/02/20 HSBC
Trip.com Group upgraded to Buy from Hold at HSBC
12/02/20 Mizuho
Trip.com Group price target raised to $38 from $33 at Mizuho
11/10/20 Credit Suisse
Trip.com Group upgraded to Outperform from Neutral at Credit Suisse
TCOM Trip.com Group
$33.18 /

-1.23 (-3.57%)

TCOM Trip.com Group
$33.18 /

-1.23 (-3.57%)

TCOM Trip.com Group
$33.18 /

-1.23 (-3.57%)

TCOM Trip.com Group
$33.18 /

-1.23 (-3.57%)

Downgrade
Fluidra downgraded to Hold from Buy at HSBC » 05:17
12/03/20
12/03
05:17
12/03/20
05:17
FLUIF

Fluidra

$0.00 /

+ (+0.00%)

HSBC analyst Pierre…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLUIF Fluidra
$0.00 /

+ (+0.00%)

10/30/20 Berenberg
Fluidra price target raised to EUR 18 from EUR 17.50 at Berenberg
10/29/20 JPMorgan
Fluidra price target raised to EUR 17 from EUR 16 at JPMorgan
09/16/20 Berenberg
Fluidra initiated with a Buy at Berenberg
05/28/20 Citi
Fluidra price target raised to EUR 12.20 from EUR 10.30 at Citi
Upgrade
Waddell & Reed upgraded to In Line from Underperform at Evercore ISI » 05:17
12/03/20
12/03
05:17
12/03/20
05:17
WDR

Waddell & Reed

$17.01 /

+0.15 (+0.89%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDR Waddell & Reed
$17.01 /

+0.15 (+0.89%)

WDR Waddell & Reed
$17.01 /

+0.15 (+0.89%)

10/05/20 Jefferies
Trian involvement could by catalyst for 'beaten down' managers, says Jefferies
07/29/20 Citi
Waddell & Reed upgraded to Neutral following Q2 report at Citi
07/29/20 Citi
Waddell & Reed upgraded to Neutral from Sell at Citi
WDR Waddell & Reed
$17.01 /

+0.15 (+0.89%)

WDR Waddell & Reed
$17.01 /

+0.15 (+0.89%)

Upgrade
Wartsila upgraded to Hold from Reduce at HSBC » 05:16
12/03/20
12/03
05:16
12/03/20
05:16
WRTBY

Wartsila

$0.00 /

+ (+0.00%)

HSBC analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WRTBY Wartsila
$0.00 /

+ (+0.00%)

10/26/20 Morgan Stanley
Wartsila price target lowered to EUR 7.60 from EUR 8.10 at Morgan Stanley
10/26/20 JPMorgan
Wartsila downgraded to Underweight from Neutral at JPMorgan
10/13/20 Goldman Sachs
Wartsila downgraded to Neutral from Buy at Goldman Sachs
10/13/20 Pareto
Wartsila upgraded to Buy from Hold at Pareto
Downgrade
Splunk downgraded to Hold from Buy at Stifel » 05:16
12/03/20
12/03
05:16
12/03/20
05:16
SPLK

Splunk

$205.91 /

-0.48 (-0.23%)

Stifel analyst Brad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

05:15 Today Summit Insights
Splunk downgraded to Hold from Buy at Summit Insights
11/25/20 Cowen
Cowen sees 'a lot of moving parts' into Splunk's Q3 results
11/23/20 KeyBanc
Splunk initiated with an Overweight at KeyBanc
11/16/20 BofA
Berry Global, Charter, Spunk & UPS removed from US 1 List at BofA
SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

Downgrade
Splunk downgraded to Hold from Buy at Summit Insights » 05:15
12/03/20
12/03
05:15
12/03/20
05:15
SPLK

Splunk

$205.91 /

-0.48 (-0.23%)

Summit Insights analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

11/25/20 Cowen
Cowen sees 'a lot of moving parts' into Splunk's Q3 results
11/23/20 KeyBanc
Splunk initiated with an Overweight at KeyBanc
11/16/20 BofA
Berry Global, Charter, Spunk & UPS removed from US 1 List at BofA
10/26/20 Stifel
SAP news impact may be company-specific for software sector, says Stifel
SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

SPLK Splunk
$205.91 /

-0.48 (-0.23%)

Downgrade
Pentair downgraded to Equal Weight from Overweight at Morgan Stanley » 05:14
12/03/20
12/03
05:14
12/03/20
05:14
PNR

Pentair

$51.38 /

-0.25 (-0.48%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNR Pentair
$51.38 /

-0.25 (-0.48%)

PNR Pentair
$51.38 /

-0.25 (-0.48%)

11/16/20 Citi
Pentair positioned for 'strong' 2021, says Citi
11/11/20
Fly Intel: Top five analyst downgrades
11/11/20 BofA
BofA double downgrades Pentair to Underperform on 'waning' COVID trends
11/11/20 BofA
Pentair downgraded to Underperform from Buy at BofA
PNR Pentair
$51.38 /

-0.25 (-0.48%)

PNR Pentair
$51.38 /

-0.25 (-0.48%)

PNR Pentair
$51.38 /

-0.25 (-0.48%)

Hot Stocks
S&P Global Platts opens consultation on WTI Midland crude in Dated Brent » 05:14
12/03/20
12/03
05:14
12/03/20
05:14
SPGI

S&P Global

$333.19 /

-0.91 (-0.27%)

S&P Global Platts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPGI S&P Global
$333.19 /

-0.91 (-0.27%)

SPGI S&P Global
$333.19 /

-0.91 (-0.27%)

12/02/20 Wells Fargo
Wells Fargo upgrades S&P Global ahead of IHS Markit combination
12/02/20 Wells Fargo
S&P Global upgraded to Overweight from Equal Weight at Wells Fargo
12/01/20 Argus
IHS Markit downgraded to Hold from Buy at Argus
12/01/20 Truist
IHS Markit downgraded to Hold from Buy at Truist
SPGI S&P Global
$333.19 /

-0.91 (-0.27%)

SPGI S&P Global
$333.19 /

-0.91 (-0.27%)

SPGI S&P Global
$333.19 /

-0.91 (-0.27%)

SPGI S&P Global
$333.19 /

-0.91 (-0.27%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.